Articles related to Psychiatry

NeuroStar is the first FDA-approved transcranial magnetic stimulation (TMS) system developed to treat major depressive disorders. With the new FDA approval, this TMS system will allow physicians to better treat patients with obsessive compulsive disorder (OCD) without the need for additional hardware.

Cannabis use increases the likelihood that patients will develop several negative health conditions, such as insomnia, anxiety, psychosis, and depression. As such, cannabis use should be prescribed carefully by physicians.

A new case study that analyzed the correlation between the use of antidepressants and suicide concluded that all patients treated with antidepressants should receive careful monitoring for clinical worsening, suicidality, or unusual changes in behavior.

There’s been a strong response to actor Will Smith’s behavior at this year’s Academy Awards, including in the medical community. In this article, psychiatrist Melissa Hankins analyzes the psychology behind the “slap heard around the world.” And commenting readers disagree vehemently.

The American Academy of Sleep Medicine (AASM) is taking issue with the US Senate’s recently passed legislation that will make daylight saving time (DST) permanent starting in 2023. AASM cautions that this permanent change would lead to health risks that include adverse cardiovascular events, mood disorders, and motor vehicle crashes. The group advocates for establishing permanent standard time instead.

The British Medical Journal reports that people who survive COVID-19 are at increased risk of an array of mental health disorders, including anxiety, depression, and opioid use disorder, cognitive decline, sleep disorders, and more. The authors recommend close monitoring of patients following infection and up-prioritizing managing their mental health disorders.